We found that knock-down of either USP14 or UCHL5 in multiple myeloma cells resulted in loss of cell viability, consistent with our previous results36 and those of other investigators using hepatocellular carcinoma and ovarian cancer cells34, 35. Here, UCHL5 is linked to plasma cell myeloma.